Trends in Amplification

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here to sign up for SAGE Journal Email Alerts today!

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McArdle, R.
Right arrow Articles by Doyle, P. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McArdle, R.
Right arrow Articles by Doyle, P. J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Trends in Amplification, Vol. 9, No. 3, 127-143 (2005)
DOI: 10.1177/108471380500900304

The WHO-DAS II: Measuring Outcomes of Hearing Aid Intervention for Adults

Rachel McArdle, PhD

Department of Communication Sciences & Disorders, University of South Florida; VA Medical Center, Audiology (126), PO Box 5005, Bay Pines, FL 33744; Rachel.mcardle{at}med.va.gov

Theresa H. Chisolm, PhD

Harvey B. Abrams, PhD

VA Medical Center, Bay Pines, FL; Department of Communication Sciences & Disorders, University of South Florida

Richard H. Wilson, PhD

James H. Quillen VA Medical Center, Mountain Home, TN; Departments of Surgery and Communicative Disorders, East Tennessee State University, Johnson City, TN

Patrick J. Doyle, PhD

VA Pittsburgh Healthcare System and Department of Communication Science and Disorders, University of Pittsburgh, School of Health and Rehabilitation Sciences, Pittsburgh, PA

The World Health Organization's Disability Assessment Scale II (WHO-DAS II) is a generic health-status instrument that provides six domain scores and a total, aggregate score. Two of the domain scores, communication and participation, and the total score, have good validity, internal-consistency reliability, and test-retest stability in individuals with adult-onset hearing loss. As such, these two domain scores and the total WHO-DAS II score may be useful as generic outcome measures to assess the effectiveness of hearing aid intervention for this population. Before the use of the WHO-DAS II in hearing aid clinical trials, however, the responsiveness of the instrument and the short and long-term outcomes to hearing aid intervention had to be determined. Responsiveness and outcomes were assessed in 380 veterans (approximately half received hearing aids and half served as controls) by examining group differences, effect-size estimates, and individual differences as a function of hearing aid intervention. For comparison, data also were obtained on two disease-specific measures, the APHAB and the HHIE. The WHO-DAS II communication domain and total scores were sufficiently responsive to hearing aid intervention for use in future studies in which group differences are to be detected. The WHO-DAS II participation domain was not sufficiently responsive to hearing aid intervention. The APHAB and HHIE, both disease-specific measures, were more sensitive to hearing aid intervention than the generic measure. The short- and long-term outcomes of hearing aid intervention were also examined in the present study. Group outcomes for hearing aid intervention can be expected to be stable for at least 6 months when measured by WHO-DAS II total score and for at least 12 months when measured by the WHO-DAS II communication domain scores. Effect-size estimates and examination of the number of individuals exhibiting change scores exceeding 90% critical differences for true changes in scores indicate that for clinical applications, disease-specific instruments are more useful than the WHO-DAS II. The findings of this study support the use of the WHO-DAS II as a generic measure in hearing aid trials research so as to allow for comparisons of healthstatus outcomes across different diseases or disorders.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
TRENDS AMPLIFHome page
M. B. Meikle, B. J. Stewart, S. E. Griest, and J. A. Henry
Tinnitus Outcomes Assessment
Trends in Amplification, September 1, 2008; 12(3): 223 - 235.
[Abstract] [PDF]


Home page
AJAHome page
J. E. Preminger and C. H. Ziegler
Can Auditory and Visual Speech Perception Be Trained Within a Group Setting?
Am J Audiol, June 1, 2008; 17(1): 80 - 97.
[Abstract] [Full Text] [PDF]